Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Breakthrough research on CD45−/CD31+/CD105+ circulating cells as potential biomarkers for gynecologic malignancies including ovarian, cervical, and endometrial cancers.